Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Dosage Calculations | 1 | 2018 | 19 | 0.620 |
Why?
|
| Intensive Care, Neonatal | 1 | 2018 | 54 | 0.600 |
Why?
|
| Twins, Conjoined | 1 | 2018 | 29 | 0.590 |
Why?
|
| Clinical Protocols | 1 | 2018 | 234 | 0.560 |
Why?
|
| Analgesics, Opioid | 4 | 2024 | 402 | 0.520 |
Why?
|
| Precision Medicine | 1 | 2018 | 306 | 0.490 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 312 | 0.490 |
Why?
|
| Prescriptions | 2 | 2024 | 40 | 0.260 |
Why?
|
| Medicaid | 2 | 2023 | 245 | 0.220 |
Why?
|
| Acute Pain | 1 | 2023 | 21 | 0.220 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2024 | 69 | 0.210 |
Why?
|
| Drug Administration Routes | 2 | 2018 | 30 | 0.190 |
Why?
|
| Ketamine | 1 | 2023 | 214 | 0.170 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 334 | 0.170 |
Why?
|
| Infant, Newborn | 5 | 2019 | 8106 | 0.150 |
Why?
|
| Phenobarbital | 1 | 2018 | 36 | 0.150 |
Why?
|
| Milk, Human | 1 | 2019 | 300 | 0.130 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2019 | 237 | 0.130 |
Why?
|
| Sildenafil Citrate | 1 | 2016 | 51 | 0.130 |
Why?
|
| Vitamin A | 1 | 2016 | 59 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 203 | 0.120 |
Why?
|
| Hypotension | 1 | 2016 | 177 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2018 | 548 | 0.110 |
Why?
|
| Micronutrients | 1 | 2014 | 67 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2016 | 184 | 0.110 |
Why?
|
| Seizures | 1 | 2018 | 873 | 0.100 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 183 | 0.100 |
Why?
|
| Analgesics | 2 | 2024 | 134 | 0.100 |
Why?
|
| Infant, Premature | 2 | 2016 | 799 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2016 | 434 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 1099 | 0.090 |
Why?
|
| Pain | 2 | 2024 | 469 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2019 | 3325 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 1804 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2023 | 713 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2019 | 169 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 537 | 0.060 |
Why?
|
| Child | 5 | 2024 | 24228 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2018 | 666 | 0.060 |
Why?
|
| Humans | 10 | 2024 | 123103 | 0.060 |
Why?
|
| Morphine | 1 | 2023 | 88 | 0.050 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2024 | 65 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 218 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2024 | 16044 | 0.050 |
Why?
|
| Linear Models | 1 | 2023 | 669 | 0.050 |
Why?
|
| Infant | 3 | 2023 | 12357 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 82 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2018 | 142 | 0.040 |
Why?
|
| United States | 2 | 2023 | 10651 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2018 | 253 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1075 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 143 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 1739 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2023 | 13888 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1136 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 720 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1681 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 500 | 0.030 |
Why?
|
| Adolescent | 2 | 2023 | 19094 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 10018 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2016 | 844 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3039 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2799 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1071 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3563 | 0.020 |
Why?
|
| Male | 3 | 2023 | 60129 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5039 | 0.020 |
Why?
|
| Female | 3 | 2023 | 65514 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3234 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1258 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 8855 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12115 | 0.010 |
Why?
|